Skip to content

Somatropin

Published: July 26, 2026Updated: July 26, 2026

Norditropin is a brand-name formulation of recombinant human growth hormone (somatropin) used to treat growth disorders in children and adults. It is prescribed for conditions including growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, and children born small for gestational age who fail to show catch-up growth. The medication is administered as a subcutaneous injection and should only be used under the supervision of a qualified healthcare provider.

Quick summary

Norditropin is a synthetic growth hormone injection used to treat growth disorders in children and growth hormone deficiency in adults.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
202829
Generic
Norditropin
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Norditropin is used to treat growth hormone deficiency in children and adults, Turner syndrome, Prader-Willi syndrome, small for gestational age with failure to catch-up growth, and idiopathic short stature. Treatment in children is typically continued until growth goals are achieved or the epiphyseal plates have closed.

As a recombinant human growth hormone, Norditropin mimics the action of naturally occurring growth hormone. It stimulates growth, cell reproduction, and cell regeneration by binding to growth hormone receptors in target tissues.

Norditropin is a prescription-only medication administered via subcutaneous injection, typically once daily. Common side effects may include injection site reactions, headache, and fluid retention. It should not be used in patients with active malignancy, diabetic retinopathy, or closed epiphyses. Growth hormone therapy requires regular monitoring of growth response, IGF-1 levels, and potential side effects.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy